feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

England cricket team criticized

trending

Delhi pollution source study ordered

trending

Markets decline on fund outflows

trending

India-South Africa betting arrests

trending

Starlink announces India pricing

trending

Sensex, Nifty slip on profit

trending

SSC CGL Tier 1 results

trending

Meesho IPO allotment status

trending

Japan earthquake triggers tsunami alert

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Toxic Cough Syrup Kills 24 Kids: Supply Chain Fail Exposed

Toxic Cough Syrup Kills 24 Kids: Supply Chain Fail Exposed

21 Nov

•

Summary

  • Investigation probes safety lapses in pharmaceutical ingredient supply.
  • Toxic chemical DEG contaminated cough syrup, killing 24 children.
  • Unlicensed distributors repackaged solvent, bypassing safety seals.

Authorities are investigating whether lapses in the pharmaceutical ingredient supply chain contributed to the deaths of at least 24 children from contaminated cough syrup. The probe focuses on a batch of Coldrif cough syrup found heavily tainted with diethylene glycol (DEG), a toxic industrial chemical. Investigators suspect the propylene glycol (PG) solvent used as the syrup's base may have been contaminated during its supply.

Concerns have been heightened as evidence suggests that unlicensed chemical distributors repackaged the PG solvent without proper seals. This practice, which violates pharmaceutical handling regulations, could have allowed the toxic DEG to enter the supply chain. The drugmaker, Sresan Pharmaceutical Manufacturer, has had its license revoked, and its founder is in custody.

The incidents cast a shadow over India's pharmaceutical sector, reviving worries about safety standards following previous deaths linked to contaminated cough syrups. While the exact source of contamination remains under investigation, the focus is on how the toxic chemical was introduced into a product intended for children, highlighting critical breaches in product integrity and regulatory oversight.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The Coldrif cough syrup was heavily contaminated with diethylene glycol (DEG), a toxic industrial chemical, which led to the deaths of 24 children.
Authorities are investigating if safety lapses in the supply chain, including repackaging of propylene glycol by unlicensed distributors, allowed the toxic DEG to contaminate the solvent.
Sresan Pharmaceutical Manufacturer produced the contaminated Coldrif cough syrup. Its manufacturing license has been revoked, and its founder is in custody.

Read more news on

Healthside-arrow

You may also like

Blood Pressure Med Recalled Over Contamination Fears

1 day ago • 53 reads

article image

Cereal Scare: 'Forever Chemicals' Found in Breakfast Foods

5 Dec • 23 reads

article image

Formosa Pharma & Rxilient Ink Eye Drug Deal

4 Dec • 25 reads

article image

700+ Syrup Makers Audited After Child Deaths

2 Dec • 39 reads

Fund Invests $50M in ACADIA Pharma

5 Dec • 11 reads

article image